EUVIMEDEUVIMED entdecken
Crossref

Distinct cutaneous α-synuclein signatures in body-first and brain-first Parkinson’s disease subtypes

Minglei Liu iD, Tingting Wen, Haiyang Luo, Tianyuan Yang, Ying Kong, Yuting Jin, Lanjun Li, Yanpeng Yuan, Xiaojing Liu, Jing Yuan, Ke Zhang, Yangyang Wang und 14 weitere

Brain · 2026

DOI: 10.1093/brain/awaf395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Minglei Liu und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Skin, Brain. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University, Three 100s.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is characterized by pathological α-synuclein (α-syn) aggregation, yet the origin of α-syn pathology (central or peripheral) remains debated. The synuclein origin and connectome model proposes two subtypes, i.e. brain-first (pathology initiating in brain structures) and body-first (originating in peripheral autonomic nerves) subtypes. In this study, we aimed to delineate cutaneous α-syn signatures between these subtypes to validate the synuclein origin and connectome model. In this cross-sectional study, 126 brain-first PD patients, 79 body-first PD patients and 60 healthy controls were enrolled. Subtype classification was based on the presence of REM sleep behaviour disorder preceding motor symptoms. All participants underwent skin biopsies at two anatomical sites: the distal leg (DL) and the posterior cervical region (C7). Intraepidermal, sudomotor and pilomotor nerve fibre densities were quantified. Phosphorylated α-syn (p-α-syn) deposition was assessed by immunostaining, and α-syn seeding activity was evaluated using real-time quaking-induced conversion. Clinical correlations and diagnostic performance were analysed systematically. Body-first PD patients exhibited more prominent non-motor symptoms (e.g. REM sleep behaviour disorder, autonomic dysfunction) and severe autonomic denervation (reduced sweat gland and pilomotor nerve densities; P < 0.01). Immunostaining revealed significantly higher p-α-syn positivity (92.4% versus 61.9%) and a greater p-α-syn diffusion coefficient (0.2 versus 0.0) in body-first versus brain-first PD patients. Body-first PD patients displayed a distal-to-proximal α-syn gradient (DL, 86.1% versus C7. 55.7%), contrasting with the proximal-dominant pattern in brain-first PD patients (DL, 40.5% versus C7, 50.8%). Body-first PD patients also demonstrated accelerated α-syn seeding activity (higher maximum fluorescence intensity, shorter time to reach threshold; P < 0.001). Cutaneous α-syn parameters were correlated strongly with non-motor symptom severity in body-first PD patients (P < 0.05). Receiver operating characteristic analysis showed that DL α-syn signatures have discriminative power for subtype differentiation (area under the curve = 0.774). Our findings provide direct pathological evidence for the body-first versus brain-first PD framework and highlight the value of skin biopsy as a minimally invasive biomarker for PD subtyping. This study contributes to precision medicine approaches targeting α-syn pathology-specific propagation pathways in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseSkinBrainHumansMaleFemaleMiddle AgedCross-Sectional StudiesAgedREM Sleep Behavior Disorder

Stichwörter der Autor:innen

Parkinson’s diseaseseeding amplification assayskin biopsysubtypesα-synuclein

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
  • NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Disease, Zhengzhou, Henan 450052, China.
  • Henan Key Laboratory of Cerebrovascular Diseases, Zhengzhou University, Zhengzhou, Henan 450052, China.
  • Henan Medical Key Laboratory of Neurogenetic and Degenerative Diseases, Zhengzhou, Henan 450052, China.
  • Department of Neurology, Kaifeng Central Hospital, Kaifeng, Henan 475000, China.
  • Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450014, China.

ORCID-Profile: Minglei Liu, Yuming Xu, Jing Yang

Förderung

  • National Natural Science Foundation of China
  • Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University
  • Three 100s
  • Program-Special Project for Training Clinician-Scientists in Clinical Research
  • Central Research Institute Fund of Chinese Academy of Medical Sciences
  • Program–Special Project for Training Clinician-Scientists in Clinical Research

Zitieren

APA

Liu, M., Wen, T., Luo, H., Yang, T., Kong, Y., Jin, Y., Li, L., Yuan, Y., Liu, X., Yuan, J., Zhang, K., Wang, Y., Li, S., Yang, T., Wang, Y., Gao, Y., Liu, H., Xue, Y., Liu, R., …, & Yang, J. (2026). Distinct cutaneous α-synuclein signatures in body-first and brain-first Parkinson’s disease subtypes. Brain. https://doi.org/10.1093/brain/awaf395

Vancouver

Liu M, Wen T, Luo H, Yang T, Kong Y, Jin Y, et al. Distinct cutaneous α-synuclein signatures in body-first and brain-first Parkinson’s disease subtypes. Brain. 2026. doi:10.1093/brain/awaf395

BibTeX
@article{Liu2026,
  author = {Liu, Minglei and Wen, Tingting and Luo, Haiyang and Yang, Tianyuan and Kong, Ying and Jin, Yuting and Li, Lanjun and Yuan, Yanpeng and Liu, Xiaojing and Yuan, Jing and Zhang, Ke and Wang, Yangyang and Li, Shuo and Yang, Ting and Wang, Yanlin and Gao, Yuan and Liu, Han and Xue, Yinge and Liu, Ruoyu and Cheng, Lin and Liu, Chen and Chen, Kaixin and Wang, Ke and Hao, Tiantian and Xu, Yuming and Yang, Jing},
  title = {Distinct cutaneous α-synuclein signatures in body-first and brain-first Parkinson’s disease subtypes},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awaf395}
}
Kostenlos starten →